Home › Compare › TJSCF vs ABBV
TJSCF yields 7.70% · ABBV yields 3.06%● Live data
📍 TJSCF pulled ahead of the other in Year 1
Combined, TJSCF + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TJSCF + ABBV for your $10,000?
Tianjin Development Holdings Limited, through its subsidiaries, supplies electricity, water, heat, and thermal power to industrial, commercial, and residential customers in the Tianjin Economic and Technological Development Area, the People's Republic of China. It operates through six segments: Utilities, Pharmaceutical, Hotel, Electrical and Mechanical, Port Services, and Elevators and Escalators. The company has an installed transmission capacity of approximately 946,000 kVA; daily water supply capacity of 425,000 tons; and steam transmission pipelines of approximately 462 kilometres, approximately 120 processing stations, and daily distribution capacity of approximately 30,000 tons. It also provides services in relation to construction of electricity supply network, application of technology related to new energy and renewable energy, and electricity construction and related technical services; and offers services in installation and maintenance of water pipes, and technical consultancy, as well as engages in the retail and wholesale of water pipes and related parts. In addition, the company is involved in the manufacture and sale of presses, and mechanical and hydroelectric equipment, as well as large scale pump units. Further, it operates Courtyard by Marriott Hong Kong, a 4-star hotel with 245 guest rooms; researches and develops medicine technology and products; manufactures and sells chemical drugs; designs, manufactures, and prints pharmaceutical packaging products, as well as sells other paper-based packaging materials; manufactures and sells elevators and escalators; operates financing leasing business; and provides port services. The company was incorporated in 1997 and is based in Central, Hong Kong. Tianjin Development Holdings Limited is a subsidiary of Tsinlien Group Company Limited.
Full TJSCF Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.